Proxima

General Proximity

This biotechnology platform develops induced-proximity medicines for pharmaceutical partners to target proteins associated with cancer, neurodegeneration and cardiometabolic diseases.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Profluent Bio

Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.

InduPro

This biotechnology company develops proximity-based protein therapeutics for patients with cancer and autoimmune diseases.

Celeris Therapeutics

The company develops artificial intelligence software to design and discover protein degrader drugs for pharmaceutical and biotechnology organisations.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Profluent

This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.